Blackstone

Stories mentioning alternative assets management giant Blackstone on Alternatives Watch.

Hedge Funds

Blackstone assets up 25% amid strong earnings growth

Blackstone reported its best business results in the firm’s 36-year history, said Chairman and CEO Stephen Schwarzman in advance of…

Private Equity

Blackstone Life Sciences adds two managing directors

Dr. Monika Vnuk and Matt Lane have joined Blackstone Life Sciences (BXLS) as managing directors based in Cambridge, Massachusetts. Dr.…

Manager News

Blacktsone validates music rights as alts assets with $1bn partnership

If there were any doubts left about the value of music rights as an alternative investment asset class, the $1…

Real Estate/Infrastructure

Blackstone sells Las Vegas Resort

Blackstone Real Estate Partners VII (BREP) has sold The Cosmopolitan of Las Vegas for $5.65 billion to a consortium that…

Manager News

Blackstone’s BioMed Realty makes big lab space play in Cambridge, UK

Blackstone portfolio company BioMed Realty is investing an estimated £850 million ($1.16 billion) to purchase two properties in Cambridge, UK,…

Private Credit

Former Credit Suisse, Barclays execs join Blackstone private credit team

Three senior leaders have joined the ranks at Blackstone’s $163 billion credit business. Blackstone Credit is the fastest growing unit…

Private Equity

Goldman Sachs alum Petrelli joins Blackstone innovations unit

Stevi Petrelli has joined Blackstone to lead its BXI Investments unit, where she will be responsible for overseeing the firm's…

Investor News

Blackstone buys minority stake in GTCR

Blackstone’s GP Stakes business will acquire a minority ownership interest in private equity firm GTCR, officials announced today. The GP…

Hedge Funds

Blackstone hedge fund portfolio reports 14% annualized gains

Blackstone reported $2.2 billion in inflows to its hedge fund portfolio in the second quarter, with the unit seeing net…

Private Equity

Blackstone commits $250m to back new CAR T-cell therapies

Blackstone Life Sciences is investing $250 million toward developing CAR T-cell therapies for immuno-oncology and autoimmune diseases, forming a new…

Back to top button